C J Beard

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Outcomes in stage I testicular seminoma: a population-based study of 9193 patients
    Clair J Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer 119:2771-7. 2013
  2. ncbi request reprint Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer
    Clair Beard
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Urology 66:1020-3. 2005
  3. ncbi request reprint Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer
    C J Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 58:19-24. 2004
  4. ncbi request reprint Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer
    Clair Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 66:403-7. 2006
  5. ncbi request reprint Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 280:969-74. 1998
  6. ncbi request reprint Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02215, USA
    Mol Urol 4:171-5;discussion 177. 2000
  7. ncbi request reprint Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, and Department of Pathology, Brigham and Women s Hospital, Boston, MA 02215, USA
    J Clin Oncol 17:168-72. 1999
  8. ncbi request reprint Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA 02215, USA
    J Clin Oncol 16:3094-100. 1998
  9. ncbi request reprint The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 49:679-84. 2001
  10. ncbi request reprint Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer
    A V D'Amico
    Brigham and Women s Hospital and Dana Farber Cancer Institute, Department of Radiation Therapy, Harvard Medical School, 75 Francis St, L 2 Level, Boston, MA 02115, USA
    JAMA 284:1280-3. 2000

Detail Information

Publications26

  1. doi request reprint Outcomes in stage I testicular seminoma: a population-based study of 9193 patients
    Clair J Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer 119:2771-7. 2013
    ..In particular, data describing long-term risks of cardiovascular disease (CVD) are conflicting...
  2. ncbi request reprint Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer
    Clair Beard
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Urology 66:1020-3. 2005
    ..Pretreatment risk groups predict for posttreatment biochemical failure (BF) after conformal radiotherapy in patients with prostate cancer and posttreatment PSADTs can predict for prostate cancer-related deaths...
  3. ncbi request reprint Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer
    C J Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 58:19-24. 2004
    ....
  4. ncbi request reprint Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer
    Clair Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 66:403-7. 2006
    ..To identify an association between perineural invasion (PNI) and cancer-specific survival in patients with prostate cancer after standard-dose external beam radiation therapy (RT)...
  5. ncbi request reprint Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, Mass 02215, USA
    JAMA 280:969-74. 1998
    ..Interstitial radiation (implant) therapy is used to treat clinically localized adenocarcinoma of the prostate, but how it compares with other treatments is not known...
  6. ncbi request reprint Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02215, USA
    Mol Urol 4:171-5;discussion 177. 2000
    ....
  7. ncbi request reprint Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, and Department of Pathology, Brigham and Women s Hospital, Boston, MA 02215, USA
    J Clin Oncol 17:168-72. 1999
    ....
  8. ncbi request reprint Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA 02215, USA
    J Clin Oncol 16:3094-100. 1998
    ..This study was performed to validate or refute the prognostic value of the previously defined calculated prostate cancer volume (cV(Ca))...
  9. ncbi request reprint The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer
    A V D'Amico
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 49:679-84. 2001
    ....
  10. ncbi request reprint Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer
    A V D'Amico
    Brigham and Women s Hospital and Dana Farber Cancer Institute, Department of Radiation Therapy, Harvard Medical School, 75 Francis St, L 2 Level, Boston, MA 02115, USA
    JAMA 284:1280-3. 2000
    ....
  11. ncbi request reprint Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study
    C J Beard
    Joint Center for Radiation Therapy, Boston, MA 02115, USA
    J Clin Oncol 15:223-9. 1997
    ..To use data from a prospective quality-of-life study to assess differences in disease-specific and general health-related quality-of-life changes after treatment with different external-beam irradiation techniques for prostate cancer...
  12. ncbi request reprint Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study
    J A Talcott
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA, USA
    J Clin Oncol 16:275-83. 1998
    ..To assess complications of therapy for early (nonmetastatic) prostate cancer...
  13. ncbi request reprint Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy
    Henry K Tsai
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Urol Oncol 23:230-7. 2005
    ..To investigate the impact of 2 months of neoadjuvant and 2 months of concurrent hormonal therapy on the acute gastrointestinal (GI) toxicities associated with 3-dimensional conformal radiation therapy (3D-CRT) for prostate adenocarcinoma...
  14. ncbi request reprint A technique for optimization of digitally reconstructed radiographs of the chest in virtual simulation
    J H Killoran
    Longwood Radiation Oncology Center, Department of Radiation Oncology, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 49:231-9. 2001
    ..We present techniques to improve DRR quality for clinical purposes. The results of two approaches to DRR optimization are presented...
  15. doi request reprint Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate
    Michele Albert
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Urol Oncol 26:147-52. 2008
    ..This study was performed to define the rectal dose constraint that would predict late rectal bleeding requiring argon plasma coagulation (APC) following prostate brachy mono-therapy...
  16. ncbi request reprint A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization
    Anthony V D'Amico
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Urology 67:780-4. 2006
    ....
  17. ncbi request reprint Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate
    Anthony V D'Amico
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Urology 62:1063-7. 2003
    ....
  18. ncbi request reprint Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization
    Rosemonde Woel
    Joint Center for Radiation Therapy, Brigham and Women s Hospital and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 62:392-6. 2005
    ..A modified intrarectal balloon (Medrad) was used for prostate gland localization and immobilization...
  19. ncbi request reprint Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy
    Daniel M Landis
    Joint Center for Radiation Therapy Residency Training Program, Harvard Medical School, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Urology 65:750-4. 2005
    ..To evaluate the risk of acute urinary retention (AUR) and sequelae after urethra-sparing magnetic resonance imaging (MRI)-guided prostate brachytherapy...
  20. ncbi request reprint Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease
    Anthony V D'Amico
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Clin Oncol 22:3726-32. 2004
    ..We investigated whether pretreatment factors predicted time to prostate cancer-specific mortality (PCSM) after conventional-dose and conformal radiation therapy (CRT)...
  21. ncbi request reprint Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy
    Michele Albert
    Department of Radiation Oncology, Brigham and Women s Hospital, 75 Francis Street, L 2 Level, Boston, MA 02115, USA
    Cancer 98:949-54. 2003
    ..This study was designed to estimate the rates of late genitourinary (GU) and rectal toxicity after magnetic resonance image (MRI)-guided prostate brachytherapy exclusively or in conjunction with external beam radiation therapy (EBRT)...
  22. ncbi request reprint Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy
    Mona V Sanghani
    Department of Radiation Oncology, The Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA, USA
    Urol Oncol 22:165-8. 2004
    ....
  23. ncbi request reprint Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer
    Mari Nakabayashi
    Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Urol Oncol 24:503-8. 2006
    ..Hyperbaric oxygen therapy can be considered a treatment option after failure of standard treatments in patients with severe radiation proctopathy...
  24. ncbi request reprint Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer
    Mark Pomerantz
    Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    J Urol 177:2146-50. 2007
    ..We tested 2 doses of the conjugated estrogen Premarin(R) in patients with androgen independent prostate cancer to determine the efficacy and safety of this widely available medication...
  25. ncbi request reprint Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects
    C Norman Coleman
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 54:191-4. 2002
    ..This study examined whether the inflammatory response within the prostate during radiotherapy would respond to the standard dose of ibuprofen as assessed by a symptom score...
  26. pmc Testicular cancer survivorship: research strategies and recommendations
    Lois B Travis
    Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA
    J Natl Cancer Inst 102:1114-30. 2010
    ..Just as testicular cancer once served as the paradigm of a curable malignancy, comprehensive follow-up studies of testicular cancer survivors can pioneer new methodologies in survivorship research for all adult-onset cancer...